Mei Yin C Polley

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration
    Lisa M McShane
    Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Room 5W130, MSC 9735, 9609 Medical Center Drive, Bethesda, MD 20892 9735, USA
    BMC Med 11:220. 2013
  2. pmc Practical modifications to the time-to-event continual reassessment method for phase I cancer trials with fast patient accrual and late-onset toxicities
    Mei Yin C Polley
    Biometric Research Branch, National Caner Institute, Executive Plaza North, Room 8124, 6130 Executive Boulevard, Rockville, MD 20852, USA
    Stat Med 30:2130-43. 2011
  3. pmc Conditional probability of survival in patients with newly diagnosed glioblastoma
    Mei Yin C Polley
    Biometric Research Branch, National Cancer Institute, National Institute of Health, Room 8124, Executive Plaza North, 6130 Executive Blvd, Rockville, MD 20892, USA
    J Clin Oncol 29:4175-80. 2011

Collaborators

  • Kathleen R Lamborn
  • Nicholas Butowski
  • Jennifer L Clarke
  • Lisa M McShane
  • James V Tricoli
  • David A Eberhard
  • Margaret M Cavenagh
  • Jill P Mesirov
  • William L Bigbee
  • P Mickey Williams
  • Deborah J Shuman
  • Richard M Simon
  • Kelly Y Kim
  • Tracy G Lively
  • James H Doroshow
  • Barbara A Conley
  • Jeremy M G Taylor

Detail Information

Publications3

  1. pmc Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration
    Lisa M McShane
    Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Room 5W130, MSC 9735, 9609 Medical Center Drive, Bethesda, MD 20892 9735, USA
    BMC Med 11:220. 2013
    ..The US National Cancer Institute plans to refer to these guidelines for review of proposals for studies involving omics tests, and it is hoped that other sponsors will adopt the checklist as well...
  2. pmc Practical modifications to the time-to-event continual reassessment method for phase I cancer trials with fast patient accrual and late-onset toxicities
    Mei Yin C Polley
    Biometric Research Branch, National Caner Institute, Executive Plaza North, Room 8124, 6130 Executive Boulevard, Rockville, MD 20852, USA
    Stat Med 30:2130-43. 2011
    ..The practical aspects of the proposed designs are discussed. The modifications presented are useful when planning phase I trials involving chemoradiation therapy...
  3. pmc Conditional probability of survival in patients with newly diagnosed glioblastoma
    Mei Yin C Polley
    Biometric Research Branch, National Cancer Institute, National Institute of Health, Room 8124, Executive Plaza North, 6130 Executive Blvd, Rockville, MD 20892, USA
    J Clin Oncol 29:4175-80. 2011
    ..For 1-year survivors, we evaluated variables that may inform subsequent survival. Motivated by the trend in data, we also evaluated the assumption of constant hazard...